RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
stockNASDAQ
Market OpenOct 20, 2026 2:55:46 PM EDT
3.63USD+0.693%(+0.02)14,937,095
Pre-marketOct 20, 2026 9:28:30 AM EDT
3.55USD-1.662%(-0.06)
RXRX Financials
In Q2 FY 2026 (ended ), Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) reported revenue of $7.67M, net income of −$131.01M, operating cash flow of −$105.95M, and assets of $1.21B.
Loading financial statements…